Incidence and Remission of Atopic Dermatitis in a German Birth Cohort
In this cohort study of children with allergic diseases, AD before school age was generally associated with a favorable long-term prognosis. However, remission was less likely in female participants, those with onset before age 2 years, those with specific serum antibodies to common allergens before school age, or those with allergic comorbidity, highlighting the need for increased clinical attention and further investigation into underlying mechanisms.
Authors
- Christoph Müller (ORCID: https://orcid.org/0000-0002-8187-9170)
- Stephanie Roll (ORCID: https://orcid.org/0000-0003-1191-3289)
- Oliver Nitsche
- Chu-Wei Hung
- Thomas Keil (ORCID: https://orcid.org/0000-0001-6124-0655)
- Julia Fricke (ORCID: https://orcid.org/0000-0002-7625-474X)
- Katja Icke (ORCID: https://orcid.org/0000-0002-4170-8430)
- Margitta Worm (ORCID: https://orcid.org/0000-0002-3449-1245)
- Antje Schuster (ORCID: https://orcid.org/0000-0003-3717-9588)
- Susanne Lau (ORCID: https://orcid.org/0000-0002-5189-4265)
- V. Wahn (ORCID: https://orcid.org/0000-0003-1218-2940)
- A. Grübl
- Linus Grabenhenrich (ORCID: https://orcid.org/0000-0002-9300-6625)
- Ulrich Wahn (ORCID: https://orcid.org/0000-0002-5723-6132)
Institutions
- University of Freiburg (DE)
- Johannes Gutenberg University Mainz (DE)
- Robert Koch Institute (DE)
- University of Würzburg (DE)
- University Medical Center Freiburg (DE)
- Humboldt-Universität zu Berlin (DE)
- Düsseldorf University Hospital (DE)
- Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie (DE)
- Schwarzwaldmilch Freiburg (Germany) (DE)
- German Centre for Cardiovascular Research (DE)
- Heinrich Heine University Düsseldorf (DE)
- University of Rostock (DE)
- Technical University of Munich (DE)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.44324
- Citations
- 1
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.00